Sphingosine 1-phosphate: A Potential Molecular Target for Ovarian Cancer Therapy?

被引：29
|
作者：
Dai, Lan [1 ,2 ]
Xia, Pu [3 ]
Di, Wen [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Renji Hosp, Dept Obstet & Gynecol, Sch Med, Shanghai 200127, Peoples R China
[2] Fudan Univ, Focus Construct Subject Shanghai Educ Dept, Shanghai Key Lab Gynecol Oncol, Shanghai 200433, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Endocrinol, Shanghai 200433, Peoples R China
来源：
CANCER INVESTIGATION | 2014年 / 32卷 / 03期
关键词：
Ovarian cancer; Sphingosine; 1-phosphate; Sphingosine kinase; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; UP-REGULATION; TNF-ALPHA; KINASE; SPHINGOSINE-1-PHOSPHATE LYASE; SIGNALING PATHWAY; PROSTATE-CANCER; DOWN-REGULATION;
D O I：
10.3109/07357907.2013.876646
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sphingosine 1-phosphate (S1P) is an important signaling regulator involved in tumor progression in multiple neoplasms. However, the role of S1P in the pathogenesis of ovarian cancer remains unclear. Herein, we summarize recent advances in understanding the impact of S1P signaling in ovarian cancer progression. S1P, aberrantly produced in ovarian cancer patients, is involved in the regulation of key cellular processes that contribute to ovarian cancer initiation and progression. Moreover, agents that block the S1P signaling pathway inhibit ovarian cancer cell growth or induce apoptosis. Hence, current evidence suggests that S1P may become a potential molecular target for ovarian cancer therapy.
引用
收藏
页码：71 / 80
页数：10
相关论文
共 50 条
  • [31] The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy
    Zheng, Xiangjin
    Li, Wan
    Ren, Liwen
    Liu, Jinyi
    Pang, Xiaocong
    Chen, Xiuping
    Kang, De
    Wang, Jinhua
    Du, Guanhua
    PHARMACOLOGY & THERAPEUTICS, 2019, 195 : 85 - 99
  • [32] Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
    Tanaka, Yuko
    Okabe, Seiichi
    Ohyashiki, Kazuma
    Gotoh, Akihiko
    ONCOLOGY LETTERS, 2022, 23 (04)
  • [33] Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair
    Sartawi, Ziad
    Schipani, Ernestina
    Ryan, Katie B.
    Waeber, Christian
    PHARMACOLOGICAL RESEARCH, 2017, 125 : 232 - 245
  • [34] Hypoxia, Therapeutic Resistance, and Sphingosine 1-Phosphate
    Cuvillier, Olivier
    Ader, Isabelle
    Bouquerel, Pierre
    Brizuela, Leyre
    Gstalder, Cecile
    Malavaud, Bernard
    ROLE OF SPHINGOLIPIDS IN CANCER DEVELOPMENT AND THERAPY, 2013, 117 : 117 - 141
  • [35] Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential
    Meshcheryakova, Anastasia
    Mechtcheriakova, Diana
    Pietschmann, Peter
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (07) : 725 - 737
  • [36] Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate
    Kihara, Akio
    Mitsutake, Susumu
    Mizutani, Yukiko
    Igarashi, Yasuyuki
    PROGRESS IN LIPID RESEARCH, 2007, 46 (02) : 126 - 144
  • [37] Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system
    Schuchardt, Mirjam
    Toelle, Markus
    Pruefer, Jasmin
    van der Giet, Markus
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) : 1140 - 1162
  • [38] Sphingosine 1-Phosphate: A Novel Target for Lung Disorders (vol 8, 296, 2017)
    Mohammed, Sabira
    Harikumar, K. B.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [39] Sphingosine 1-phosphate signalling and termination at lipid phosphate receptors
    Pyne, S
    Pyne, NJ
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1582 (1-3): : 121 - 131
  • [40] Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system
    Okada, Taro
    Kajimoto, Taketoshi
    Jahangeer, Saleem
    Nakamura, Shun-ichi
    CELLULAR SIGNALLING, 2009, 21 (01) : 7 - 13
12345